We are live on ! Find out more
AXGN icon

Axogen

133 hedge funds and large institutions have $251M invested in Axogen in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,084% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $137K

49% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 37

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

0.88% more ownership

Funds ownership: 74.8%75.68% (+0.88%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1% less funds holding

Funds holding: 134133 (-1)

14% less capital invested

Capital invested by funds: $291M → $251M (-$40M)

Holders
133
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
55
Reduced
37
Closed
21
Calls
$1.62M
Puts
$137K
Net Calls
+$1.49M
Net Calls Change
+$33K

AXGN Hedge Fund Activity: Q1 2022 in Review

133 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q1 2022, worth a combined $251M — down 14% from $291M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AXGN positions and 21 closed out — a net gain of 1 holder — while 55 added to existing stakes and 37 trimmed.

The largest buyer was SCW Capital Management, opening a new position worth an estimated $2.36M. The largest seller was BAMCO Inc, exiting entirely with an estimated $4.08M sold.

  • 133 institutional investors held Axogen (AXGN) as of Q1 2022, down from 134 in Q4 2021.
  • Funds reported $251M of Axogen stock for Q1 2022, down 14% quarter-over-quarter.
  • 22 funds opened new Axogen positions in Q1 2022 and 21 closed out, a net change of +1 holder.
  • The largest Axogen buyer in Q1 2022 was SCW Capital Management, an estimated $2.36M added.
  • The largest Axogen seller in Q1 2022 was BAMCO Inc, an estimated $4.08M sold.

Based on aggregated 13F filings for Q1 2022.